EYETECH PHARMACEUTICALS INC 4
4 · EYETECH PHARMACEUTICALS INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
CHANEY PAUL G
Chief Operating Officer
Transactions
- Sale
Common Stock
2005-07-01$12.68/sh−2,800$35,504→ 30,595 total - Exercise/Conversion
Common Stock
2005-07-01$3.50/sh+2,800$9,800→ 33,395 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-07-01−2,800→ 194,829 totalExercise: $3.50From: 2004-07-30Exp: 2013-07-30→ Common Stock (2,800 underlying)
Footnotes (1)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.